Dentium CO., LTD (KRX:145720)

Market Cap	501.91B
Revenue (ttm)	372.49B
Net Income (ttm)	52.76B
Shares Out	8.62M
EPS (ttm)	6,117.00
PE Ratio	9.51
Forward PE	8.86
Dividend	600.00 (1.03%)
Ex-Dividend Date	Dec 27, 2024

Volume	32,998
Average Volume	48,949
Open	58,000
Previous Close	58,500
Day's Range	57,300 - 58,200
52-Week Range	54,000 - 85,800
Beta	0.90
RSI	47.53
Earnings Date	Nov 7, 2025

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 853
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2024, Dentium CO., LTD's revenue was 407.81 billion, an increase of 3.72% compared to the previous year's 393.19 billion. Earnings were 72.71 billion, a decrease of -24.67%.